Clinical Trial Update: Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of alemtuzumab with glucocorticoids for newly diagnosed acute graft-versus-host disease after allogeneic stem …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Alemtuzumab (Campath) (alemtuzumab)
• glucocorticoids (glucocorticoids)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Breast Cancer, Chronic Myeloproliferative Disorders | Phase 2 | Status: COMPLETED